Display Settings:

Format

Send to:

Choose Destination
    Acta Psychiatr Scand. 1990 Feb;81(2):168-9.

    Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.

    Source

    Gehah Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Israel.

    Abstract

    Development of neuroleptic malignant syndrome (NMS) following discontinuation of high-dose and high-potency neuroleptic agents is described. This case, although rare and atypical, should alert clinicians to consider the possibility of NMS as a complication of abrupt neuroleptic drug withdrawal. It is suggested that dopaminergic imbalance, as opposed to excessive dopaminergic blockade, may also play a role in the precipitation of NMS.

    PMID:
    1970216
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk